There’s a moment in “Euphoria” Season 3 when Cassie (Sydney Sweeney) shrieks, “What is happening right now?!” and that sums it up, as a whole. You’ll be saying the same thing as you watch every other ...

While Marvel blockbusters bend over backward to keep characters around forever, Eric Kripke's black-comic action series takes a hard look at the consequences of chasing childlike fantasies into ...

My passion for looter shooters has burned quite brightly for over 15 years and Borderlands is the flame that lit the fuse. With Borderlands 4, Gearbox proves it still knows how to bring the boom.

"The Handmaid's Tale" is nowhere near its end. Less than a year after Hulu's landmark, eventually exhausting signature series ended, the world of Gilead returns in "The Testaments," based on author ...

Military goons round up liberals for “thought crimes” and throw them in prison camps. Political leaders cut through the separation of church and state like a hot knife through butter. Government ...

It’s been 10 years since the T-Mobile Arena officially opened its doors and helped to usher in an era of major professional sports and top-tier entertainment in Las Vegas. On April 6, 2016, Las Vegas ...

View post: Another award-winning beer brand files Chapter 11 bankruptcy ...

Within the hallways of the sinister sanatorium where Resident Evil Requiem’s opening hours take place lies some of the most frightening encounters I’ve experienced in the series to date. With my ...

Zendaya and Robert Pattinson play a couple upended when one confesses to coming close to committing a horrific crime. By Manohla Dargis When you purchase a ticket for an independently reviewed film ...

Smelling like burnt rubber and mall body mist, the pop provocateur’s loud, wild new album swerves hard into club antagonism. WOR$T GIRL is most successful as an ...

The White House plans to create retirement-savings plans for workers who don’t have access to one through their employer, offering up to $1,000 a year in matching funds, which could boost the ...

The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to July 6. The review extension comes after the company submitted additional data ...